SCHEMBL17875846

SCHEMBL17875846

c1ccc2c(c1)oc1cc(-c3ccc4c(c3)-c3ccc(-c5ccc6oc7ccccc7c6c5)cc3COC4)ccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
RAB9A P51151 4/20 0.38
MAPT P10636 4/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 3/20 0.38
AHR P35869 2/20 0.38
HPGD P15428 2/20 0.38
ATM Q13315 1/20 0.37
HCRTR1 O43613 1/20 0.36
MMP12 P39900 1/20 0.35
MMP13 P45452 1/20 0.35
HSP90AA1 P07900 1/20 0.35
HSP90AB1 P08238 1/20 0.35
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34
HTT P42858 1/20 0.34
PRKDC P78527 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875831 0.96 AHR (0.41) NPC1MEN1KMT2ARAB9AMAPT
SCHEMBL17875838 0.96 MAPT (0.41) NPC1MEN1KMT2ARAB9AMAPT
SCHEMBL17875894 0.95 MEN1 (0.41) NPC1MEN1KMT2ARAB9AMAPT
SCHEMBL17875901 0.91 MAPT (0.45) NPC1MEN1KMT2ARAB9AMAPT
SCHEMBL17875893 0.91 AHR (0.45) NPC1MEN1KMT2ARAB9AMAPT
SCHEMBL17875857 0.90 PLA2G2A (0.40) NPC1MEN1KMT2ARAB9AMAPT
SCHEMBL17875841 0.90 PLA2G2A (0.40) NPC1MEN1KMT2ARAB9AMAPT
SCHEMBL17875844 0.90 NPC1 (0.38) NPC1MEN1KMT2ARAB9AMAPT
SCHEMBL17875856 0.90 NPC1 (0.38) NPC1MEN1KMT2ARAB9AMAPT
SCHEMBL17875845 0.88 PRKDC (0.39) NPC1MEN1KMT2ARAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 NPC1 2673/4885MEN1 448/4885KMT2A 1757/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 NPC1 2673/4885MEN1 448/4885KMT2A 1757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.